Jonathan Rosenberg MD
@DrRosenbergMSK
Followers
3K
Following
3K
Media
10
Statuses
490
Chief, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center.
New York, NY
Joined May 2018
@Uromigos @OncoAlert 🎥Everybody should watch the video :) but here is a one slide summary that is higher resolution so you are not zooming in on your 📱 #Uromigoslive #Uromigosshorts @BladderCancerUS
0
1
8
Excited for Izabright for patients s/p EV+P. The first of many 2nd gen ADCs with dual antigen targets.
Treatment after EVP in bladder cancer is undefined. Izalontamab brenitecan (HER2/3 TROP2 ADC) has good activity in bladder+lung cancer. A global randomised phase III has started enrolment 👉 Iza Bren alone vs platinum chemo in previously treated pts (including EVP). @OncoAlert
0
5
13
🎶 Wondering how to tackle variant histologies in bladder cancer? Think of them as music genres—same stage, different openers (neoadj.) and headliners (1st line tx). 🎤 From micropapillary to plasmacytoid—each has a style & strategy. 🎧 Watch here ⬇️ @Uromigos @Dr_Aggen
The UromigosLive 2025 meeting presents #UromigosShorts videos on GU Oncology topics. The videos with the most views win a prize at #UromigosLive November 7-8th in Nashville, TN. Below, Dr. David Aggen discusses : Variant Histology Bladder Cancer.
0
12
22
The UromigosLive 2025 meeting presents #UromigosShorts videos on GU Oncology topics. The videos with the most views win a prize at #UromigosLive November 7-8th in Nashville, TN. Below, Dr. David Aggen discusses : Variant Histology Bladder Cancer.
1
15
38
We are looking for a talented genitourinary medical oncologist to join our group. Join a great team focused on eradicating GU cancers! https://t.co/zp0iyJ6rS7
0
8
43
Love it, but Américas Team too busy curing cancer to spend time on social media
While the Americas 🇨🇦 🇺🇸 are 0-6 down in the Uromigos cup 🏆, with team 🇦🇺 🇦🇺 Australia 🇦🇺 🇦🇺 🦘 🦘 winning the last photo competition . Here @montypal if the USA 🇺🇸 🇺🇸 🇺🇸 capital. 3 points available for the final photo !!! ❤️ =points @OncoAlert @montypal @DrChoueiri
0
1
7
Excited to serve as captain of #UromigosTeamNA, which will be competing in #UromigosLive25. @tompowles1 & @brian_rini have assembled a superteam for me including @kalasri3 @pmcancercentre, #McDermott @BIDMChealth, @DrRosenbergMSK @MSKCancerCenter, @WalterStadler5 @CityofHopeChi &
0
18
49
Astute discussion from @DrRosenbergMSK for neoadjuvant #bladdercancer landscape — highest pCR rates and overall survival improved!! @myESMO #ESMO25 #ESMOAmbassadors @OncoAlert
2
24
63
@TiansterZhang @DrRosenbergMSK @myESMO @OncoAlert @DrChoueiri @montypal @PGrivasMDPhD @shilpaonc @ERPlimackMD @apolo_andrea @neerajaiims @QianJanieQin Full written coverage of @DrRosenbergMSK’s #ESMO25 discussant presentation on perioperative EV + pembrolizumab in cisplatin-ineligible MIBC — now available on @UroToday 👇 written by @chavarriagaj @myESMO @UroDocAsh 📝
0
7
11
Awesome poster from @MichalSternsch on platinum-based chemotherapy after EV + pembro in metastatic urothelial carcinoma! @DrRosenbergMSK @MSKCancerCenter @MSK_DeptOfMed @ASCO #ASCO25
2
6
33
Congrats to our stellar medical student Alyssa Arbuisa on her abstract evaluating cutaneous rash with I/O response. #ASCO2025 @MSKCancerCenter
1
2
21
🌟Great contribution from Dr. Jonathan E. Rosenberg Risk-Adaptive Neoadjuvant Chemotherapy and Adjuvant Immunotherapy #ASCO25 @OncoAlert 🟠 Multiple perioperative trials now exploring chemo/IO and ADC/IO combinations: — GC + IO (Durva, Pembro, Nivo) — EV-based strategies —
0
10
39
Insightful talk by @MariaJRibal on perioperative management on MIBC with balance of pros/cons, rationale, data! Several P2 trials & NIAGARA reported, awaiting KN866, GC +/- Nivo & EV-IO trials! #ASCO25 @OncoAlert @ASCO @shilpaonc @DrRosenbergMSK @arkhaki @koshkin85 @FaltasLab
1
15
38
#PREDICT trial investigates biomarker-guided treatment for advanced #ProstateCancer. @DrRanaMcKay @UCSanDiego and @CaPsurvivorship @DanaFarber to discuss the PREDICT trial — a biomarker-driven approach for mCRPC patients post-ARPI. 💡 DNA and RNA profiling 🔍 Targeted arms:
0
7
27
I am very privileged to work with @bbmdmsk on a daily basis. This is a truly well deserved recognition.
Special moment and a tribute to our legendary chair when our very own @bbmdmsk delivered the prestigious Whitmore lecture at the SUO session at the #AUA2025 @MSKCancerCenter @NYSAUA
2
1
33
Join us for the AUA-IBCG Bladder Cancer Forum April 28, 2–5 pm 🗓️ #AUA25 @AmerUrological @IBCG_BladderCA @KKBree
@PGrivasMDPhD @LauraBukavinaMD @shilpaonc @NehaVapiwala @WesKassouf @pcvblack @pjhensley11 @h_alahmadie @JoshMeeks @BenjaminPradere @siadaneshmand @VigneshPackiam
1
20
54
Dr Hikmat Al-Ahmadie highlights markers in #urothelialcarcinoma which may be therapeutically targeted including MMRd/MSI, FGFR3, and antibody-drug conjugate (ADC) markers such as NECTIN-4 and HER2 #gupath @GU_Path_Society #USCAP2025
0
19
50
On to the keynote lecture by Michael Morris from @MSKCancerCenter #TransatlanticExchange Fascinating to see how radioligands can improve survival AND HRQoL… Yet so much remains to be done and improved!
0
9
45
I am pleased to share that @MSKCancerCenter’s state-of-the-art cancer care pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center. We are deeply grateful to Ken for his extraordinary generosity and all he
3
13
103